Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The investigators aim to investigate whether the routine use of the probiotic formulation
VSL#3 co-prescribed with antibiotics reduces the incidence of both Antibiotic associated
diarrhoea and Clostridium Difficile associated diarrhoea.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
National Health Service, United Kingdom
Collaborators:
Ferring Pharmaceuticals Hull and East Yorkshire Hospitals NHS Trust Hull University Teaching Hospitals NHS Trust North Bristol NHS Trust South London and Maudsley NHS Foundation Trust Wrightington, Wigan and Leigh NHS Foundation Trust